Main menu (tertiary)
What is prostate cancer?
Prostate cancer is a malignancy that develops from cells of the prostate gland that may eventually spread outside the gland to other parts of the body. The prostate gland is about the size of a walnut, although it can grow larger, and is behind the base of the penis and under the bladder. The main function of the prostate is to make fluid that carries sperm.
Prostate cancer is one of the most common types of cancer among American men and is usually found in men older than 65. Each year, approximately 2,000 Arkansans will be told they have prostate cancer. While most prostate cancers grow very slowly; some spread quickly to other areas.
In general, men 50 and older should receive annual prostate cancer screenings. However, African-American men and men with close family members who have had prostate cancer are at greatest risk. These men should begin prostate cancer screenings at age 40.
What are the symptoms?
- Problems passing urine, such as pain, difficulty starting or stopping the stream or dribbling
- Low back pain
- Pain with ejaculation
- Blood in urine or semen
da Vinci® Prostatectomy
What preventive tests are available?
Finding cancer early means treatment begins earlier. Contact your physician to schedule your annual prostate examination. Click here to request an appointment online.
Prostate Screening Exam
UroNav MR/Ultrasound Fusion
- an elevated prostate-specific antigen (PSA) level greater than four
- a negative prior transrectal ultrasound-guided biopsy with continued elevation or rising PSA
- a positive digital rectal examination with negative transrectal ultrasound-guided biopsy
What are the patient outcomes?
The best advocates for the care you can expect from Baptist Health are the patients themselves. Hear this patient's success story.
Baptist Health used new robotic technology to surgically remove James’ cancer with more precision and delicacy than ever possible before. Hear his story.
Baptist Health Medical Center-North Little Rock performed the state’s first minimally invasive prostate cancer treatment using da Vinci robotic-assisted technology.